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Introduction
Chronic recurrent multifocal osteomyelitis (CRMO) is
the most severe presentation of the autoinflammatory
bone disorder chronic nonbacterial osteomyelitis (CNO).
The pathophysiology of CNO remains to be determined.
We recently demonstrated reduced activation of mito-
gen-activated protein kinases ERK1 and 2 in monocytes
from CRMO patients responsible for impaired activation
of the transcription factor signaling protein (Sp-)1. This
resulted in failure to express the immuno-modulatory
cytokine IL-10. The IL10 gene, together with its homo-
logues IL19 and IL20, is organized in the 145 kb span-
ning IL10 cytokine cluster on chromosome 1q32. In
most cells, including monocytes, IL-10 cytokine family
members are co-regulated in response to certain stimuli.
IL-10 and IL-19 mainly have immune-modulating func-
tions, while IL-20 acts as a pro-inflammatory cytokine
contributing to inflammatory bone-loss. The NLRP3
inflammasome is a multi-protein complex forming in
response to innate stimuli, subsequently mediating the
cleavage and release of IL-1b. Enhanced inflammasome
activation in IL-10 deficient mice was linked with bone-
loss. Convincing evidence of this mechanism playing a
role in CNO, however, is lacking.
Objectives
The aim of our study was to determine i) IL-10 cytokine
family expression patterns in CRMO monocytes, ii)
molecular mechanisms underlying impaired cytokine
expression, and iii) potential effects on inflammasome-
dependent cytokine secretion.
Methods
Ex vivo isolated monocytes from CRMO patients were
cultured in the absence or presence of LPS. Expression
patterns of cytokines were monitored on the transcrip-
tional (mRNA) and protein level. Effects of impaired
Sp-1 activation on cytokine expression were investigated
through forced expression, chemical inhibition, or
knock-down of Sp-1.
Results
We saw reduced expression of anti-inflammatory cyto-
kines IL-10 and IL-19 and unaffected expression of
IL-20 in CRMO monocytes when compared to controls.
We for the first time demonstrate Sp-1 recruitment to
the IL19 promoter, governing IL-19 expression in
monocytes. Impaired expression of IL-10 and IL-19 in
CRMO monocytes was caused by reduced binding of
Sp-1 to regulatory regions. Expression of IL-20 was
independent of Sp-1. Reduced IL-10 and IL-19 secretion
from CRMO monocytes mediated increased activity of
the NLRP3 inflammasome, as assessed by IL-1b secre-
tion. Addition of recombinant IL-10 or IL-19 reversed
these findings.
Conclusion
Impaired activation of Sp-1 in monocytes from CRMO
patients contributes to reduced expression of IL-10 and
IL-19, resulting in an imbalance between pro- (IL-20)
and anti-inflammatory IL-10 cytokine family members.
Subsequently enhanced NLRP3 inflammasome activation
results in IL-1b secretion which may in turn contribute
to inflammatory bone-loss. A complete understanding of
the molecular pathophysiology of CNO will aid in devel-
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